SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-065928
Filing Date
2024-03-12
Accepted
2024-03-12 16:31:00
Documents
15
Period of Report
2024-03-12
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d783185d8k.htm   iXBRL 8-K 27556
2 EX-3.1 d783185dex31.htm EX-3.1 27420
  Complete submission text file 0001193125-24-065928.txt   190036

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lxrx-20240312.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrx-20240312_lab.xml EX-101.LAB 18740
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrx-20240312_pre.xml EX-101.PRE 11712
16 EXTRACTED XBRL INSTANCE DOCUMENT d783185d8k_htm.xml XML 3856
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 24742585
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)